Image of the Day: Flying Fish Robot
Image of the Day: Flying Fish Robot
The developers envision their device could be used to collect water samples in hazardous environments.
Image of the Day: Flying Fish Robot
Image of the Day: Flying Fish Robot

The developers envision their device could be used to collect water samples in hazardous environments.

The developers envision their device could be used to collect water samples in hazardous environments.

pharma & biotech
Biogen, Eisai End Two Late-Stage Trials for Alzheimer’s Treatment
Biogen, Eisai End Two Late-Stage Trials for Alzheimer’s Treatment
Emily Makowski | Sep 16, 2019
The widely expected move comes months after the companies scrapped trials of another Alzheimer’s drug.
China’s First Cloned Kitten, Garlic
China’s First Cloned Kitten, Garlic
Nicoletta Lanese | Sep 6, 2019
Owner Huang Yu dug up his deceased cat to give its cells to the pet-cloning company Sinogene.
Image of the Day: Enamel Repair
Image of the Day: Enamel Repair
Nicoletta Lanese | Sep 3, 2019
Scientists engineered a new material that could be developed for use in treating tooth decay.
Fixing the Flaws in Animal Research
Fixing the Flaws in Animal Research
Diana Kwon | Sep 1, 2019
Many preclinical studies carried out in vivo are poorly designed and generate irreproducible data, but efforts to address the problem are on the rise.
Cigall Kadoch Unravels Chromatin’s Role in Cancer
Cigall Kadoch Unravels Chromatin’s Role in Cancer
Chia-Yi Hou | Sep 1, 2019
The Dana-Farber Cancer Institute researcher is developing cancer therapeutics based on how the physical structure of DNA contributes to the disease.
UCSD Eye Doctor Resigns After Investigation into Ties with ChinaUCSD Eye Doctor Resigns After Investigation into Ties with China
UCSD Eye Doctor Resigns After Investigation into Ties with China
Nicoletta Lanese | Aug 23, 2019
The FDA and the university have audited Kang Zhang for breaches in bioethics and a failure to follow research protocols.
Immune Cell Bank Bets on Future CAR T Success
Immune Cell Bank Bets on Future CAR T Success
Nicoletta Lanese | Aug 16, 2019
The company Cell Vault offers to hold consumers’ T cells for later use, but scientists suggest the service would benefit very few users.
Leaders of AveXis Out Over Doctored Gene Therapy Data
Leaders of AveXis Out Over Doctored Gene Therapy Data
Kerry Grens | Aug 14, 2019
Novartis, which bought the biotech firm in 2018, announced that the company’s top scientists have left, and news reports say it’s because they were involved in using manipulated data to get the gene therapy Zolgensma approved.
Some Data Backing Novartis Gene-Therapy Approval Manipulated: FDA
Some Data Backing Novartis Gene-Therapy Approval Manipulated: FDA
Nicoletta Lanese | Aug 7, 2019
The agency is now evaluating the implications of the corrupted data behind Zolgensma and whether to “take action” against the pharmaceutical company.